Literature DB >> 2990150

Peripheral nervous tissue injury induced by galactocerebroside and galactocerebroside immune complexes.

N Tsukada, C S Koh, N Yanagisawa, T Taketomi, P O Behan.   

Abstract

It was demonstrated that New Zealand Albino rabbits sensitized to galactocerebroside had high levels of anti-galactocerebroside antibody and of immune complexes. The rabbits was high titers of immune complexes developed demyelination in the peripheral nerves. Lesion were produced in the peripheral nerves of mice by the i.m. injection of galactocerebroside immune complexes. The lesions were characterized by axonal degeneration, infiltrating macrophages containing myelin debris, and an inflammatory infiltrate of polymorphonuclear and mononuclear cells. Rabbit immunoglobulin and mouse C3 were observed around the endoneural blood vessels. These results suggest that galactocerebroside immune complexes may play a role in the pathogenesis of mouse peripheral nerve lesions, due to the production of vasculomyelinopathy.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2990150     DOI: 10.1007/bf00690959

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  24 in total

1.  The initial structural lesion in serum-induced demyelination in vitro.

Authors:  M B Bornstein; C S Raines
Journal:  Lab Invest       Date:  1976-10       Impact factor: 5.662

2.  Experimental allergic neuritis induced by sensitization with galactocerebroside.

Authors:  T Saida; K Saida; S H Dorfman; D H Silberberg; A J Sumner; M C Manning; R P Lisak; M J Brown
Journal:  Science       Date:  1979-06-08       Impact factor: 47.728

3.  Landry-Guillain-Barré-Strohl syndrome and immune-complex nephritis.

Authors:  P O Behan; L M Lowenstein; M Stilmant; D S Sax
Journal:  Lancet       Date:  1973-04-21       Impact factor: 79.321

4.  Detection of immune complexes in experimental allergic neuritis.

Authors:  C S Koh; T Nakano; N Tsukada; N Yanagisawa; A Okano; T Taketomi
Journal:  J Neurol Sci       Date:  1984-02       Impact factor: 3.181

5.  Nervous tissue injury induced by immune complexes.

Authors:  N Tsukada; C S Koh; N Yanagisawa; H Tsukagoshi
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088

6.  Late onset of Guillain-Barré syndrome.

Authors:  C M Poser; P O Behan
Journal:  J Neuroimmunol       Date:  1982-08       Impact factor: 3.478

7.  Antiserum-mediated demyelination in vivo: a sequential study using intraneural injection of experimental allergic neuritis serum.

Authors:  K Saida; T Saida; M J Brown; D H Silberberg; A K Asbury
Journal:  Lab Invest       Date:  1978-11       Impact factor: 5.662

8.  Disseminated vasculomyelinopathy: an immune complex disease.

Authors:  L Reik
Journal:  Ann Neurol       Date:  1980-04       Impact factor: 10.422

9.  the role of autoantibody and immune complexes in the pathogenesis of Guillain-Barré syndrome.

Authors:  S D Cook; P C Dowling
Journal:  Ann Neurol       Date:  1981       Impact factor: 10.422

10.  Binding of soluble immune complexes to human lymphoblastoid cells. II. Use of Raji cells to detect circulating immune complexes in animal and human sera.

Authors:  A N Theofilopoulos; C B Wilson; V A Bokisch; F J Dixon
Journal:  J Exp Med       Date:  1974-11-01       Impact factor: 14.307

View more
  3 in total

1.  Antineuronal antibodies in small cell lung carcinoma--a significance for paraneoplastic syndromes?

Authors:  W Grisold; M Drlicek; W Popp; K Jellinger
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

2.  Neuropsychiatric manifestations of systemic lupus erythematosus: the value of anticardiolipin, antigangliosides and antigalactocerebrosides antibodies.

Authors:  L T Costallat; R M de Oliveira; M B Santiago; W Cossermelli; A M Samara
Journal:  Clin Rheumatol       Date:  1990-12       Impact factor: 2.980

Review 3.  Severe Guillain-Barré syndrome associated with chronic hepatitis B: A case report and literature review.

Authors:  Jiajun Wei; Shenhan Duan
Journal:  Medicine (Baltimore)       Date:  2021-12-03       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.